Antimicrobial resistance patterns of Pseudomonas aeruginosa isolated from canine clinical cases at a veterinary academic hospital in South Africa

Journal of the South African Veterinary Association

 
 
Field Value
 
Title Antimicrobial resistance patterns of Pseudomonas aeruginosa isolated from canine clinical cases at a veterinary academic hospital in South Africa
 
Creator Eliasi, Ulemu L. Sebola, Dikeledi Oguttu, James W. Qekwana, Daniel N.
 
Subject Veterinary Public-Health antimicrobial resistance; Pseudomonas aeruginosa; dogs; multi-drug resistance; veterinary.
Description Although Pseudomonas aeruginosa (P. aeruginosa) can infect both animals and humans, there is a paucity of veterinary studies on antimicrobial resistance of P. aeruginosa in South Africa. Secondary data of canine clinical cases presented at the hospital from January 2007 to December 2013 was used. The following information was recorded: type of sample, the date of sampling and the antimicrobial susceptibility results. Frequencies, proportions and their 95% confidence intervals were calculated for all the categorical variables. In total, 155 P. aeruginosa isolates were identified and included in this study. All the isolates were resistant to at least one antimicrobial (AMR), while 92% were multi-drug resistant (MDR). Most isolates were resistant to lincomycin (98%), penicillin-G (96%), orbifloxacin (90%), trimethoprim-sulfamethoxazole (90%) and doxycycline (87%). A low proportion of isolates was resistant to imipenem (6%), tobramycin (12%), amikacin (16%) and gentamicin (18%). A high proportion of MDR-P. aeruginosa isolates was resistant to amoxycillin-clavulanic acid (99%), tylosin (99%), chloramphenicol (97%) and doxycycline (96%). Few (6%) of MDR-P. aeruginosa isolates were resistant to imipenem. Pseudomonas aeruginosa was associated with infections of various organ systems in this study. All P. aeruginosa isolates of P. aeruginosa exhibited resistance to β-lactams, fluoroquinolones and lincosamides. Clinicians at the hospital in question should consider these findings when treating infections associated with P. aeruginosa.
 
Publisher AOSIS
 
Contributor
Date 2020-09-22
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — —
Format text/html application/epub+zip text/xml application/pdf
Identifier 10.4102/jsava.v91i0.2052
 
Source Journal of the South African Veterinary Association; Vol 91 (2020); 6 pages 2224-9435 1019-9128
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://journals.jsava.aosis.co.za/index.php/jsava/article/view/2052/2635 https://journals.jsava.aosis.co.za/index.php/jsava/article/view/2052/2634 https://journals.jsava.aosis.co.za/index.php/jsava/article/view/2052/2636 https://journals.jsava.aosis.co.za/index.php/jsava/article/view/2052/2633
 
Coverage Pretoria — —
Rights Copyright (c) 2020 Ulemu L. Eliasi, Dikeledi Sebola, James W. Oguttu, Daniel N. Qekwana https://creativecommons.org/licenses/by/4.0
ADVERTISEMENT